High blood pressure is prevalent in obesity and in diabetes, both conditions with insulin resistance. To test whether hypertension is associated with insulin resistance independently of obesity and glucose intolerance, we measured insulin sensitivity (using the euglycemic insulin-clamp technique), glucose turnover (using [3H]glucose isotope dilution), and whole-body glucose oxidation (using indirect calorimetry) in 13 young subjects (38 +/- 2 years [+/- SEM]) with untreated essential hypertension (165 +/- 6/112 +/- 3 mm Hg), normal body weight, and normal glucose tolerance. In the postabsorptive state, all measures of glucose metabolism were normal. During steady-state euglycemic hyperinsulinemia (about 60 microU per milliliter), hepatic glucose production and lipolysis were effectively suppressed, and glucose oxidation and potassium disposal were normally stimulated. However, total insulin-induced glucose uptake was markedly impaired (3.80 +/- 0.32 vs. 6.31 +/- 0.42 mg per minute per kilogram of body weight in 11 age- and weight-matched controls, P less than 0.001). Thus, reduced nonoxidative glucose disposal (glycogen synthesis and glycolysis) accounted for virtually all the defect in overall glucose uptake (1.19 +/- 0.24 vs. 3.34 +/- 0.44 mg per minute per kilogram, P less than 0.001). Total glucose uptake was inversely related to systolic or mean blood pressure (r = 0.76 for both, P less than 0.001). These results provide preliminary evidence that essential hypertension is an insulin-resistant state. We conclude that this insulin resistance involves glucose but not lipid or potassium metabolism, is located in peripheral tissues but not the liver, is limited to nonoxidative pathways of intracellular glucose disposal, and is directly correlated with the severity of hypertension.
This article has been cited by other articles:
Freel, E M, Tsorlalis, I K, Lewsey, J D, Latini, R, Maggioni, A P, Solomon, S, Pitt, B, Connell, J M C, McMurray, J J V
(2009). Aldosterone status associated with insulin resistance in patients with heart failure--data from the ALOFT study. Heart
95: 1920-1924
[Abstract][Full Text]
Ni, X.-P., van Dijk, C., Pearce, D., Humphreys, M. H.
(2009). Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of \#947;-melanocyte-stimulating hormone. Exp Physiol
94: 867-876
[Abstract][Full Text]
Zhou, M.-S., Schulman, I. H., Raij, L.
(2009). Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Am. J. Physiol. Heart Circ. Physiol.
296: H833-H839
[Abstract][Full Text]
Muniyappa, R., Hall, G., Kolodziej, T. L, Karne, R. J, Crandon, S. K, Quon, M. J
(2008). Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am. J. Clin. Nutr.
88: 1685-1696
[Abstract][Full Text]
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., Eckel, R. H.
(2008). The Metabolic Syndrome. Endocr. Rev.
29: 777-822
[Abstract][Full Text]
Hedderson, M. M., Ferrara, A.
(2008). High Blood Pressure Before and During Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus. Diabetes Care
31: 2362-2367
[Abstract][Full Text]
Landsberg, L.
(2008). Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites. Arch Intern Med
168: 1607-1608
[Full Text]
Despres, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodes-Cabau, J., Bertrand, O. F., Poirier, P.
(2008). Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk. Arterioscler. Thromb. Vasc. Bio.
28: 1039-1049
[Abstract][Full Text]
Gentile, M. T., Vecchione, C., Marino, G., Aretini, A., Di Pardo, A., Antenucci, G., Maffei, A., Cifelli, G., Iorio, L., Landolfi, A., Frati, G., Lembo, G.
(2008). Resistin Impairs Insulin-Evoked Vasodilation. Diabetes
57: 577-583
[Abstract][Full Text]
Despres, J.-P., Brewer, H. B.
(2008). Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance. Eur Heart J Suppl
10: B1-B3
[Full Text]
Sironi, A. M., Pingitore, A., Ghione, S., De Marchi, D., Scattini, B., Positano, V., Muscelli, E., Ciociaro, D., Lombardi, M., Ferrannini, E., Gastaldelli, A.
(2008). Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat. Hypertension
51: 282-288
[Abstract][Full Text]
Conen, D., Ridker, P. M., Mora, S., Buring, J. E., Glynn, R. J.
(2007). Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study. Eur Heart J
28: 2937-2943
[Abstract][Full Text]
Riserus, U., Arnlov, J., Berglund, L.
(2007). Long-Term Predictors of Insulin Resistance: Role of lifestyle and metabolic factors in middle-aged men. Diabetes Care
30: 2928-2933
[Abstract][Full Text]
Schindler, C.
(2007). Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?. Ther Adv Cardiovasc Dis
1: 7-26
[Abstract]
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., Sechi, L. A.
(2007). Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients. Diabetes Care
30: 2349-2354
[Abstract][Full Text]
Farah, V., Elased, K. M., Morris, M.
(2007). Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet. Am. J. Physiol. Heart Circ. Physiol.
293: H1083-H1089
[Abstract][Full Text]
Reaven, G. M.
(2007). The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?. J. Am. Coll. Nutr.
26: 191-195
[Full Text]
Kono, M., Tatsumi, K., Saibara, T., Nakamura, A., Tanabe, N., Takiguchi, Y., Kuriyama, T.
(2007). Obstructive Sleep Apnea Syndrome Is Associated With Some Components of Metabolic Syndrome. Chest
131: 1387-1392
[Abstract][Full Text]
McLaughlin, T., Abbasi, F., Lamendola, C., Reaven, G.
(2007). Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity. Arch Intern Med
167: 642-648
[Abstract][Full Text]
Nisoli, E., Clementi, E., Carruba, M. O., Moncada, S.
(2007). Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome?. Circ. Res.
100: 795-806
[Abstract][Full Text]
Kashyap, S. R, Defronzo, R. A
(2007). The insulin resistance syndrome: physiological considerations. Diabetes and Vascular Disease Research
4: 13-19
[Abstract]
Gumieniak, O., Perlstein, T. S., Williams, J. S., Hopkins, P. N., Brown, N. J., Raby, B. A., Williams, G. H.
(2007). Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension. Hypertension
49: 461-466
[Abstract][Full Text]
Bangalore, S., Messerli, F. H., Potter, B. J., LeLorier, J., Epstein, B. J., Cooper-DeHoff, R. M., Bosch, J., Yusuf, S., Gerstein, H.
(2007). Effect of Ramipril on the Incidence of Diabetes. NEJM
356: 522-524
[Full Text]
Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., Steinberger, J.
(2006). Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation
114: 2710-2738
[Abstract][Full Text]
the Metascreen Writing Committee,
(2006). The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care
29: 2701-2707
[Abstract][Full Text]
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., Sechi, L. A.
(2006). Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study. J. Clin. Endocrinol. Metab.
91: 3457-3463
[Abstract][Full Text]
Ruggeri, P., Brunori, A., Cogo, C. E., Storace, D., Di Nardo, F., Burattini, R.
(2006). Enhanced sympathetic reactivity associates with insulin resistance in the young Zucker rat. Am. J. Physiol. Regul. Integr. Comp. Physiol.
291: R376-R382
[Abstract][Full Text]
Reaven, G. M
(2006). The metabolic syndrome: is this diagnosis necessary?. Am. J. Clin. Nutr.
83: 1237-1247
[Abstract][Full Text]
Campos-Rodriguez, F., Grilo-Reina, A., Perez-Ronchel, J., Merino-Sanchez, M., Gonzalez-Benitez, M. A., Beltran-Robles, M., Almeida-Gonzalez, C.
(2006). Effect of Continuous Positive Airway Pressure on Ambulatory BP in Patients With Sleep Apnea and Hypertension: A Placebo-Controlled Trial. Chest
129: 1459-1467
[Abstract][Full Text]
Thornley-Brown, D., Wang, X., Wright, J. T. Jr, Randall, O. S., Miller, E. R., Lash, J. P., Gassman, J., Contreras, G., Appel, L. J., Agodoa, L. Y., Cheek, D., for the African American Study of Kidney Disease a,
(2006). Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.. Arch Intern Med
166: 797-805
[Abstract][Full Text]
Quyyumi, A. A.
(2006). Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps. J Am Coll Cardiol
47: S66-S71
[Abstract][Full Text]
Zanolin, M. E., Tosi, F., Zoppini, G., Castello, R., Spiazzi, G., Dorizzi, R., Muggeo, M., Moghetti, P.
(2006). Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome: Assessment by principal component analysis in young hyperandrogenic women. Diabetes Care
29: 372-378
[Abstract][Full Text]
Kahn, R., Buse, J., Ferrannini, E., Stern, M.
(2005). The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care
28: 2289-2304
[Abstract][Full Text]
Cozzolino, D., Sasso, F. C., Cataldo, D., Gruosso, D., Giammarco, A., Cavalli, A., Di Maggio, C., Renzo, G., Salvatore, T., Giugliano, D., Torella, R.
(2005). Acute Pressor and Hormonal Effects of {beta}-Endorphin at High Doses in Healthy and Hypertensive Subjects: Role of Opioid Receptor Agonism. J. Clin. Endocrinol. Metab.
90: 5167-5174
[Abstract][Full Text]
Bloomgarden, Z. T.
(2005). Second World Congress on the Insulin Resistance Syndrome: Hypertension, cardiovascular disease, and treatment approaches. Diabetes Care
28: 2073-2080
[Full Text]
Kim, S. H., Abbasi, F., Chu, J. W., McLaughlin, T. L., Lamendola, C., Polonsky, K. S., Reaven, G. M.
(2005). Rosiglitazone Reduces Glucose-Stimulated Insulin Secretion Rate and Increases Insulin Clearance in Nondiabetic, Insulin-Resistant Individuals. Diabetes
54: 2447-2452
[Abstract][Full Text]
Potenza, M. A., Marasciulo, F. L., Chieppa, D. M., Brigiani, G. S., Formoso, G., Quon, M. J., Montagnani, M.
(2005). Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am. J. Physiol. Heart Circ. Physiol.
289: H813-H822
[Abstract][Full Text]
He, J., Gu, D., Wu, X., Chen, J., Duan, X., Chen, J., Whelton, P. K.
(2005). Effect of Soybean Protein on Blood Pressure: A Randomized, Controlled Trial. ANN INTERN MED
143: 1-9
[Abstract][Full Text]
Lemieux, A. M., Diehl, C. J., Sloniger, J. A., Henriksen, E. J.
(2005). Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats. J. Appl. Physiol.
99: 357-362
[Abstract][Full Text]
Masuo, K., Katsuya, T., Fu, Y., Rakugi, H., Ogihara, T., Tuck, M. L.
(2005). Lys418Asn Polymorphism of the {alpha}2-Adrenoceptor Gene Relates to Serum Uric Acid Levels But Not to Insulin Sensitivity. Hypertension
46: 144-150
[Abstract][Full Text]
Sloniger, J. A., Saengsirisuwan, V., Diehl, C. J., Dokken, B. B., Lailerd, N., Lemieux, A. M., Kim, J. S., Henriksen, E. J.
(2005). Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat. Am. J. Physiol. Endocrinol. Metab.
288: E1074-E1081
[Abstract][Full Text]
Velkoska, E., Cole, T. J., Morris, M. J.
(2005). Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am. J. Physiol. Endocrinol. Metab.
288: E1236-E1243
[Abstract][Full Text]
Ferrannini, E.
(2005). Insulin and Blood Pressure: Connected on a Circumference?. Hypertension
45: 347-348
[Full Text]
Poirier, P., Lemieux, I., Mauriege, P., Dewailly, E., Blanchet, C., Bergeron, J., Despres, J.-P.
(2005). Impact of Waist Circumference on the Relationship Between Blood Pressure and Insulin: The Quebec Health Survey. Hypertension
45: 363-367
[Abstract][Full Text]
Morisco, C., Condorelli, G., Trimarco, V., Bellis, A., Marrone, C., Condorelli, G., Sadoshima, J., Trimarco, B.
(2005). Akt Mediates the Cross-Talk Between {beta}-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes. Circ. Res.
96: 180-188
[Abstract][Full Text]
Kim, S. H, Reaven, G. M
(2004). The metabolic syndrome: one step forward, two steps back. Diabetes and Vascular Disease Research
1: 68-75
[Abstract]
Gokce, N.
(2004). L-Arginine and Hypertension. J. Nutr.
134: 2807S-2811S
[Abstract][Full Text]
Parvanova, A., Iliev, I., Filipponi, M., Dimitrov, B. D., Vedovato, M., Tiengo, A., Trevisan, R., Remuzzi, G., Ruggenenti, P.
(2004). Insulin Resistance and Proliferative Retinopathy: A Cross-Sectional, Case-Control Study in 115 Patients with Type 2 Diabetes. J. Clin. Endocrinol. Metab.
89: 4371-4376
[Abstract][Full Text]
Kanauchi, M., Kimura, K., Akai, Y., Saito, Y.
(2004). Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease. Nephrol Dial Transplant
19: 2025-2029
[Abstract][Full Text]
Frisbee, J. C.
(2004). Enhanced arteriolar {alpha}-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J. Appl. Physiol.
97: 764-772
[Abstract][Full Text]
Kim, S. H., Abbasi, F., Reaven, G. M.
(2004). Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance. Diabetes Care
27: 1998-2002
[Abstract][Full Text]
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., Kahn, S. E.
(2004). Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome. Diabetes
53: 2087-2094
[Abstract][Full Text]
Xing, G., Shimosawa, T., Ogihara, T., Matsui, H., Itakura, K., Qingyou, X., Asano, T., Ando, K., Fujita, T.
(2004). Angiotensin II-Induced Insulin Resistance Is Enhanced in Adrenomedullin-Deficient Mice. Endocrinology
145: 3647-3651
[Abstract][Full Text]
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., Ferrannini, E.
(2004). Visceral Fat in Hypertension: Influence on Insulin Resistance and {beta}-Cell Function. Hypertension
44: 127-133
[Abstract][Full Text]
Donati, G, Stagni, B, Piscaglia, F, Venturoli, N, Morselli-Labate, A M, Rasciti, L, Bolondi, L
(2004). Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut
53: 1020-1023
[Abstract][Full Text]
Saad, M. F., Rewers, M., Selby, J., Howard, G., Jinagouda, S., Fahmi, S., Zaccaro, D., Bergman, R. N., Savage, P. J., Haffner, S. M.
(2004). Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study. Hypertension
43: 1324-1331
[Abstract][Full Text]
Kubaszek, A., Markkanen, A., Eriksson, J. G., Forsen, T., Osmond, C., Barker, D. J. P., Laakso, M.
(2004). The Association of the K121Q Polymorphism of the Plasma Cell Glycoprotein-1 Gene with Type 2 Diabetes and Hypertension Depends on Size at Birth. J. Clin. Endocrinol. Metab.
89: 2044-2047
[Abstract][Full Text]
Erdos, B., Snipes, J. A., Miller, A. W., Busija, D. W.
(2004). Cerebrovascular Dysfunction in Zucker Obese Rats Is Mediated by Oxidative Stress and Protein Kinase C. Diabetes
53: 1352-1359
[Abstract][Full Text]
Rewers, M., Zaccaro, D., D'Agostino, R., Haffner, S., Saad, M. F., Selby, J. V., Bergman, R., Savage, P.
(2004). Insulin Sensitivity, Insulinemia, and Coronary Artery Disease: The Insulin Resistance Atherosclerosis Study. Diabetes Care
27: 781-787
[Abstract][Full Text]
Goodfriend, T. L., Calhoun, D. A.
(2004). Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy. Hypertension
43: 518-524
[Abstract][Full Text]
Shinozaki, K., Ayajiki, K., Nishio, Y., Sugaya, T., Kashiwagi, A., Okamura, T.
(2004). Evidence for a Causal Role of the Renin-Angiotensin System in Vascular Dysfunction Associated With Insulin Resistance. Hypertension
43: 255-262
[Abstract][Full Text]
Laffer, C. L., Laniado-Schwartzman, M., Nasjletti, A., Elijovich, F.
(2004). 20-HETE and Circulating Insulin in Essential Hypertension With Obesity. Hypertension
43: 388-392
[Abstract][Full Text]
Grundy, S. M.
(2003). Inflammation, Hypertension, and the Metabolic Syndrome. JAMA
290: 3000-3002
[Full Text]
Rheaume, C., Waib, P.-H., Kouame, N'G., Nadeau, A., Lacourciere, Y., Joanisse, D. R., Simoneau, J.-A., Cleroux, J.
(2003). Effects of Intense and Prolonged Exercise on Insulin Sensitivity and Glycogen Metabolism in Hypertensive Subjects. Circulation
108: 2653-2659
[Abstract][Full Text]
De Leo, V., la Marca, A., Petraglia, F.
(2003). Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome. Endocr. Rev.
24: 633-667
[Abstract][Full Text]
Haffner, S. M., D'Agostino, R. Jr., Festa, A., Bergman, R. N., Mykkanen, L., Karter, A., Saad, M. F., Wagenknecht, L. E.
(2003). Low Insulin Sensitivity (Si = 0) in Diabetic and Nondiabetic Subjects in the Insulin Resistance Atherosclerosis Study: Is it associated with components of the metabolic syndrome and nontraditional risk factors?. Diabetes Care
26: 2796-2803
[Abstract][Full Text]
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., Tuck, M. L.
(2003). Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation. Hypertension
42: 474-480
[Abstract][Full Text]
Haffner, S., Taegtmeyer, H.
(2003). Epidemic Obesity and the Metabolic Syndrome. Circulation
108: 1541-1545
[Full Text]
Watkins, L. L., Sherwood, A., Feinglos, M., Hinderliter, A., Babyak, M., Gullette, E., Waugh, R., Blumenthal, J. A.
(2003). Effects of Exercise and Weight Loss on Cardiac Risk Factors Associated With Syndrome X. Arch Intern Med
163: 1889-1895
[Abstract][Full Text]
Yavuz, D., Koc, M., Toprak, A., Akp{iota}nar, I., Velioglu, A., Deyneli, O., Haklar, G., Akalln, S.
(2003). Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients. Journal of Renin-Angiotensin-Aldosterone System
4: 197-203
[Abstract]
Schoeffler, A. J., Ruiz, C. R., Joubert, A. M., Yang, X., LiCata, V. J.
(2003). Salt Modulates the Stability and Lipid Binding Affinity of the Adipocyte Lipid-binding Proteins. J. Biol. Chem.
278: 33268-33275
[Abstract][Full Text]
Vecchione, C., Aretini, A., Maffei, A., Marino, G., Selvetella, G., Poulet, R., Trimarco, V., Frati, G., Lembo, G.
(2003). Cooperation Between Insulin and Leptin in the Modulation of Vascular Tone. Hypertension
42: 166-170
[Abstract][Full Text]
Tezcan, H., Yavuz, D., Toprak, A., Akpmar, I., Koc, M., Deyneli, O., Akalm, S.
(2003). Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients. Journal of Renin-Angiotensin-Aldosterone System
4: 119-123
[Abstract]
Reaven, G. M.
(2003). Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease. J. Clin. Endocrinol. Metab.
88: 2399-2403
[Full Text]
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., Horwitz, R. I.
(2003). Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic Stroke. Stroke
34: 1431-1436
[Abstract][Full Text]
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., Horwitz, R. I.
(2003). Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology
60: 1447-1451
[Abstract][Full Text]
Shen, B.-J., Todaro, J. F., Niaura, R., McCaffery, J. M., Zhang, J., Spiro III, A., Ward, K. D.
(2003). Are Metabolic Risk Factors One Unified Syndrome? Modeling the Structure of the Metabolic Syndrome X. Am J Epidemiol
157: 701-711
[Abstract][Full Text]
Golden, S. H., Wang, N.-Y., Klag, M. J., Meoni, L. A., Brancati, F. L.
(2003). Blood Pressure in Young Adulthood and the Risk of Type 2 Diabetes in Middle Age. Diabetes Care
26: 1110-1115
[Abstract][Full Text]
Bloomgarden, Z. T.
(2003). American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25-26 August 2002, Washington, DC. Diabetes Care
26: 1297-1303
[Full Text]
Chen, H., Sullivan, G., Yue, L. Q., Katz, A., Quon, M. J.
(2003). QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am. J. Physiol. Endocrinol. Metab.
284: E804-E812
[Abstract][Full Text]
Dunder, K., Lind, L., Zethelius, B., Berglund, L., Lithell, H.
(2003). Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ
326: 681-681
[Abstract][Full Text]
Steinberger, J., Daniels, S. R.
(2003). Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children: An American Heart Association Scientific Statement From the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation
107: 1448-1453
[Full Text]
Raji, A., Seely, E. W., Bekins, S. A., Williams, G. H., Simonson, D. C.
(2003). Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients. Diabetes Care
26: 172-178
[Abstract][Full Text]
(2002). Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance. Hypertension
40: 679-686
[Abstract][Full Text]
Henry, P., Thomas, F., Benetos, A., Guize, L.
(2002). Impaired Fasting Glucose, Blood Pressure and Cardiovascular Disease Mortality. Hypertension
40: 458-463
[Abstract][Full Text]
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Horwitz, R. I.
(2002). Insulin resistance and risk for stroke. Neurology
59: 809-815
[Abstract][Full Text]
Kinnick, T. R., Youngblood, E. B., O'Keefe, M. P., Saengsirisuwan, V., Teachey, M. K., Henriksen, E. J.
(2002). Exercise Effects on Muscle Insulin Signaling and Action: Selected Contribution: Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat. J. Appl. Physiol.
93: 805-812
[Abstract][Full Text]
Nishimoto, Y., Tomida, T., Matsui, H., Ito, T., Okumura, K.
(2002). Decrease in Renal Medullary Endothelial Nitric Oxide Synthase of Fructose-Fed, Salt-Sensitive Hypertensive Rats. Hypertension
40: 190-194
[Abstract][Full Text]
Cruz, M. L., Huang, T. T-K., Johnson, M. S., Gower, B. A., Goran, M. I.
(2002). Insulin Sensitivity and Blood Pressure in Black and White Children. Hypertension
40: 18-22
[Abstract][Full Text]
Miller, A. W., Tulbert, C., Puskar, M., Busija, D. W.
(2002). Enhanced Endothelin Activity Prevents Vasodilation to Insulin in Insulin Resistance. Hypertension
40: 78-82
[Abstract][Full Text]
Uwaifo, G. I., Parikh, S. J., Keil, M., Elberg, J., Chin, J., Yanovski, J. A.
(2002). Comparison of Insulin Sensitivity, Clearance, and Secretion Estimates Using Euglycemic and Hyperglycemic Clamps in Children. J. Clin. Endocrinol. Metab.
87: 2899-2905
[Abstract][Full Text]
Shintani, M., Ikegami, H., Fujisawa, T., Kawaguchi, Y., Ohishi, M., Katsuya, T., Higaki, J., Shimamoto, K., Ogihara, T.
(2002). Leptin Gene Polymorphism Is Associated with Hypertension Independent of Obesity. J. Clin. Endocrinol. Metab.
87: 2909-2912
[Abstract][Full Text]
Erdos, B., Miller, A. W., Busija, D. W.
(2002). Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am. J. Physiol. Heart Circ. Physiol.
282: H2060-H2065
[Abstract][Full Text]
Bankir, L., Ahloulay, M., Devreotes, P. N., Parent, C. A.
(2002). Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved?. Am. J. Physiol. Renal Physiol.
282: F376-F392
[Abstract][Full Text]
Arima, S., Kohagura, K., Takeuchi, K., Taniyama, Y., Sugawara, A., Ikeda, Y., Abe, M., Omata, K., Ito, S.
(2002). Biphasic Vasodilator Action of Troglitazone on the Renal Microcirculation. J. Am. Soc. Nephrol.
13: 342-349
[Abstract][Full Text]
Arauz-Pacheco, C., Parrott, M. A., Raskin, P.
(2002). The Treatment of Hypertension in Adult Patients With Diabetes. Diabetes Care
25: 134-147
[Full Text]
Irving, R.J, Walker, B.R, Noon, J.P, Watt, G.C.M, Webb, D.J, Shore, A.C
(2002). Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health. Cardiovasc Res
53: 271-276
[Abstract][Full Text]
Shinozaki, K., Hirayama, A., Nishio, Y., Yoshida, Y., Ohtani, T., Okamura, T., Masada, M., Kikkawa, R., Kodama, K., Kashiwagi, A.
(2001). Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol
38: 1821-1828
[Abstract][Full Text]
Duka, I., Shenouda, S., Johns, C., Kintsurashvili, E., Gavras, I., Gavras, H.
(2001). Role of the B2 Receptor of Bradykinin in Insulin Sensitivity. Hypertension
38: 1355-1360
[Abstract][Full Text]
Previous
